SynthesisDiabetes, obesity & metabolism2026

GLP-1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta-analysis including the SOUL trial.

Masashi Hasebe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.